Vital Signs: Carbapenem-Resistant Enterobacteriaceae
March 5, 2013 | Report
Carbapenem-resistant Enterobacteriaceae are recognized in health care settings as a cause of difficut to treat infections associated with high mortality.
You are now viewing 1 - 10 of 35 results
March 5, 2013 | Report
Carbapenem-resistant Enterobacteriaceae are recognized in health care settings as a cause of difficut to treat infections associated with high mortality.
February 28, 2013 | Journal Article
Seasonal and age variations seen in hospital MRSA infection rates.
November 12, 2012 | Report
In this statement presented by 25 national health organizations, a set of principles are presented which represent their commitment to conserving and replenishing antibiotic resources.
May 1, 2011 | Journal Article
During the H1N1 outbreak, the authors of this study monitored disease activity by analyzing public messages, "tweets," on the social networking site Twitter. The study established a model for monitoring disease outbreaks in real time.
January 1, 2011 | Report
Learn how harnessing the power of prediction markets could offer public health officials and policy-makers a valuable tool in protecting public health.
January 31, 2012 | Pioneering Ideas Blog Post
We were quite proud and excited by the recent news that the work of two Pioneer Portfolio grantees placed first and second in the Most Influential RWJF Research Articles of 2011.
March 18, 2010 | Program Result Report
An "Avian Influenza Market," a "prediction market," modeled on the principles of commodities futures trading, forecast the timing and extent of a possible human-to-human bird flu outbreak.
March 1, 2013 | Journal Article
Increases in the prevalence of drug-resistant pneumonia present a major infection control challenge for public health.
January 1, 2007 | Book
Policy Responses to the Growing Threat of Antibiotic Resistance
January 1, 2012 | Journal Article
When patients are likely to develop immunity to infection, the duration of antibiotic treatments can be shortened without harm, thus delaying the spread of drug resistance and its concomitant public health impacts, according to this model-based analysis.